JP2017527563A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017527563A5 JP2017527563A5 JP2017512775A JP2017512775A JP2017527563A5 JP 2017527563 A5 JP2017527563 A5 JP 2017527563A5 JP 2017512775 A JP2017512775 A JP 2017512775A JP 2017512775 A JP2017512775 A JP 2017512775A JP 2017527563 A5 JP2017527563 A5 JP 2017527563A5
- Authority
- JP
- Japan
- Prior art keywords
- ala
- carbon atoms
- optionally substituted
- val
- alkynyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462045248P | 2014-09-03 | 2014-09-03 | |
| US62/045,248 | 2014-09-03 | ||
| US201462087040P | 2014-12-03 | 2014-12-03 | |
| US62/087,040 | 2014-12-03 | ||
| US201562149370P | 2015-04-17 | 2015-04-17 | |
| US62/149,370 | 2015-04-17 | ||
| US201562164305P | 2015-05-20 | 2015-05-20 | |
| US62/164,305 | 2015-05-20 | ||
| PCT/US2015/048059 WO2016036801A1 (en) | 2014-09-03 | 2015-09-02 | Cytotoxic benzodiazepine derivatives |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019192174A Division JP6802340B2 (ja) | 2014-09-03 | 2019-10-21 | 細胞障害性ベンゾジアゼピン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017527563A JP2017527563A (ja) | 2017-09-21 |
| JP2017527563A5 true JP2017527563A5 (enExample) | 2019-10-03 |
| JP6606545B2 JP6606545B2 (ja) | 2019-11-13 |
Family
ID=54140691
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017512775A Expired - Fee Related JP6606545B2 (ja) | 2014-09-03 | 2015-09-02 | 細胞障害性ベンゾジアゼピン誘導体 |
| JP2019192174A Expired - Fee Related JP6802340B2 (ja) | 2014-09-03 | 2019-10-21 | 細胞障害性ベンゾジアゼピン誘導体 |
| JP2020195666A Active JP7132311B2 (ja) | 2014-09-03 | 2020-11-26 | 細胞障害性ベンゾジアゼピン誘導体 |
| JP2022133442A Ceased JP2022166293A (ja) | 2014-09-03 | 2022-08-24 | 細胞障害性ベンゾジアゼピン誘導体 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019192174A Expired - Fee Related JP6802340B2 (ja) | 2014-09-03 | 2019-10-21 | 細胞障害性ベンゾジアゼピン誘導体 |
| JP2020195666A Active JP7132311B2 (ja) | 2014-09-03 | 2020-11-26 | 細胞障害性ベンゾジアゼピン誘導体 |
| JP2022133442A Ceased JP2022166293A (ja) | 2014-09-03 | 2022-08-24 | 細胞障害性ベンゾジアゼピン誘導体 |
Country Status (33)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017526682A (ja) * | 2014-09-02 | 2017-09-14 | イミュノジェン， インコーポレイテッド | 抗体薬物複合体組成物の製剤化方法 |
| ES2815353T3 (es) | 2014-09-03 | 2021-03-29 | Immunogen Inc | Derivados de benzodiazepina citotóxicos |
| BR112017027254A2 (pt) | 2015-06-29 | 2019-05-14 | Immunogen, Inc. | anticorpos anti-cd123 e conjugados e derivados dos mesmos |
| US10081640B2 (en) | 2015-07-21 | 2018-09-25 | Immunogen, Inc. | Methods of preparing cytotoxic benzodiazepine derivatives |
| WO2017091745A1 (en) | 2015-11-25 | 2017-06-01 | Immunogen, Inc. | Pharmaceutical formulations and methods of use thereof |
| KR20180115687A (ko) * | 2016-02-05 | 2018-10-23 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | Gcc-표적 항체-약물 콘주게이트 |
| WO2018098258A2 (en) * | 2016-11-23 | 2018-05-31 | Immunogen, Inc. | Selective sulfonation of benzodiazepine derivatives |
| WO2018119196A1 (en) | 2016-12-23 | 2018-06-28 | Immunogen, Inc. | Immunoconjugates targeting adam9 and methods of use thereof |
| US20180230218A1 (en) | 2017-01-04 | 2018-08-16 | Immunogen, Inc. | Met antibodies and immunoconjugates and uses thereof |
| WO2018183494A1 (en) | 2017-03-31 | 2018-10-04 | Immunogen, Inc. | Cd19-targeting antibody-drug conjugates |
| CN115448926A (zh) | 2017-04-20 | 2022-12-09 | 伊缪诺金公司 | 制备吲哚啉并苯并二氮杂䓬衍生物的方法 |
| US11638760B2 (en) | 2017-11-27 | 2023-05-02 | Mersana Therapeutics, Inc. | Pyrrolobenzodiazepine antibody conjugates |
| TW201929908A (zh) | 2017-12-21 | 2019-08-01 | 美商梅爾莎納醫療公司 | 吡咯并苯并二氮呯抗體共軛物 |
| TWI897855B (zh) | 2018-10-26 | 2025-09-21 | 美商免疫遺傳股份有限公司 | Ｅ ｐ Ｃ Ａ Ｍ 抗體、可活化抗體及免疫偶聯物以及其用途 |
| JP2022527449A (ja) * | 2019-03-21 | 2022-06-02 | イミュノジェン・インコーポレーテッド | 細胞結合剤－薬物複合体の調製方法 |
| CA3139180A1 (en) * | 2019-03-27 | 2020-10-01 | Daiichi Sankyo Company, Limited | Combination of antibody-pyrrolobenzodiazepine derivative conjugate and parp inhibitor |
| CA3154072A1 (en) | 2019-09-13 | 2021-03-18 | Mythic Therapeutics, Inc. | Antigen-binding protein constructs and uses thereof |
| AU2023298568A1 (en) | 2022-06-30 | 2025-01-09 | Toray Industries, Inc. | Pharmaceutical composition for cancer treatment and/or prevention |
| CN119212735A (zh) * | 2023-04-27 | 2024-12-27 | 石药集团巨石生物制药有限公司 | 一种抗体药物偶联物 |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3453266A (en) | 1966-03-14 | 1969-07-01 | American Home Prod | 1,2,5-benzothiadiazepine 1,1-dioxides |
| US3506646A (en) | 1966-06-27 | 1970-04-14 | American Home Prod | Process for the preparation of 7h-pyrido (1,2-b)(1,2,5)benzothiadiazepine 5,5 - dioxides and pyrrolo(1,2-b)(1,2,5)benzothiadiazepine 5,5-dioxides |
| US3875162A (en) | 1973-07-26 | 1975-04-01 | Squibb & Sons Inc | Certain 6H-pyrimido{8 1,2-c{9 {8 1,3,5{9 benzothiadiaza compounds |
| US4003905A (en) | 1974-12-11 | 1977-01-18 | E. R. Squibb & Sons, Inc. | Diels-alder adducts of benzdiazepines |
| US4444688A (en) | 1981-05-11 | 1984-04-24 | Ciba-Geigy Corporation | Imidazobenzothiadiazepines |
| JP2920385B2 (ja) | 1988-08-18 | 1999-07-19 | 武田薬品工業株式会社 | １，２，５‐ベンゾチアジアゼピン誘導体，その製造法および用途 |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| DE69233745D1 (de) | 1991-12-02 | 2008-10-23 | Cambridge Antibody Tech | Herstellung von Autoantikörpern auf Phagenoberflächen ausgehend von Antikörpersegmentbibliotheken |
| CA2076465C (en) | 1992-03-25 | 2002-11-26 | Ravi V. J. Chari | Cell binding agent conjugates of analogues and derivatives of cc-1065 |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| US20080152586A1 (en) | 1992-09-25 | 2008-06-26 | Avipep Pty Limited | High avidity polyvalent and polyspecific reagents |
| US6355780B1 (en) | 1995-02-22 | 2002-03-12 | Yeda Research And Development Co. Ltd. | Antibodies to the death domain motifs of regulatory proteins |
| WO1999006587A2 (en) | 1997-08-01 | 1999-02-11 | Morphosys Ag | Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex |
| US6156746A (en) | 1998-08-25 | 2000-12-05 | Bristol-Myers Squibb Company | 1,2,5-benzothiadiazepine-1,1-dioxides with n-2 imidazolylalkyl substituents |
| ATE320436T1 (de) | 1998-08-27 | 2006-04-15 | Spirogen Ltd | Dimere pyrrolobenzodiazepine |
| US7115396B2 (en) | 1998-12-10 | 2006-10-03 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| DK1242401T3 (da) | 1999-11-24 | 2007-05-07 | Immunogen Inc | Cytotoksiske midler, der omfatter taxaner, og den terapeutiske anvendelse deraf |
| JP5291279B2 (ja) | 2000-09-08 | 2013-09-18 | ウニヴェルジテート・チューリッヒ | 反復モジュールを含む反復タンパク質の集合体 |
| US6441163B1 (en) | 2001-05-31 | 2002-08-27 | Immunogen, Inc. | Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| US6716821B2 (en) | 2001-12-21 | 2004-04-06 | Immunogen Inc. | Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same |
| US6756397B2 (en) | 2002-04-05 | 2004-06-29 | Immunogen, Inc. | Prodrugs of CC-1065 analogs |
| GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
| WO2004013093A2 (en) | 2002-08-02 | 2004-02-12 | Immunogen, Inc. | Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| ATE499116T1 (de) | 2002-08-16 | 2011-03-15 | Immunogen Inc | Vernetzer mit hoher reaktivität und löslichkeit und ihre verwendung bei der herstellung von konjugaten für die gezielte abgabe von kleinmolekularen arzneimitteln |
| CN1795009B (zh) | 2002-11-07 | 2014-07-09 | 伊谬诺金公司 | 抗-cd33抗体及其用途 |
| FR2850654A1 (fr) | 2003-02-03 | 2004-08-06 | Servier Lab | Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| CR20170291A (es) | 2003-05-20 | 2017-07-27 | Immunogen Inc | Agentes citotoxicos mejorados que comprenden nuevos maitansinóides |
| US7276497B2 (en) | 2003-05-20 | 2007-10-02 | Immunogen Inc. | Cytotoxic agents comprising new maytansinoids |
| CN103554261B (zh) | 2003-07-21 | 2017-03-01 | 伊缪诺金公司 | Ca6抗原特异性细胞毒性偶联物及其应用方法 |
| US7834155B2 (en) | 2003-07-21 | 2010-11-16 | Immunogen Inc. | CA6 antigen-specific cytotoxic conjugate and methods of using the same |
| EP1675857B1 (en) * | 2003-10-22 | 2011-07-13 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |
| WO2005085260A1 (en) | 2004-03-09 | 2005-09-15 | Spirogen Limited | Pyrrolobenzodiazepines |
| US8039588B2 (en) | 2004-05-21 | 2011-10-18 | The Uab Research Foundation | Variable lymphocyte receptors |
| BRPI0510883B8 (pt) | 2004-06-01 | 2021-05-25 | Genentech Inc | composto conjugado de droga e anticorpo, composição farmacêutica, método de fabricação de composto conjugado de droga e anticorpo e usos de uma formulação, de um conjugado de droga e anticorpo e um agente quimioterapêutico e de uma combinação |
| BRPI0516284A (pt) | 2004-09-23 | 2008-09-02 | Genentech Inc | anticorpo construìdo com cisteìna, método de selecionar anticorpos, compostos conjugados de droga-anticorpo, composição farmacêutica, método para matar ou inibir a proliferação de células de tumor, métodos de inibir a proliferação celular e o crescimento de células de tumor, artigo manufaturado e método para produzir um composto |
| WO2006065533A2 (en) | 2004-11-29 | 2006-06-22 | Seattle Genetics, Inc. | Engineered antibodies and immunoconjugates |
| AU2006213662B2 (en) | 2005-02-11 | 2010-08-05 | Immunogen, Inc. | Process for preparing stable drug conjugates |
| EP1902131B1 (en) | 2005-07-08 | 2009-11-11 | University of Zurich | Phage display using cotranslational translocation of fusion polypeptides |
| US7772485B2 (en) | 2005-07-14 | 2010-08-10 | Konarka Technologies, Inc. | Polymers with low band gaps and high charge mobility |
| ITRM20050416A1 (it) | 2005-08-03 | 2007-02-04 | Uni Degli Studi Di Roma Tor Vergata | Derivati delle benzodiazepine e loro usi in campo medico. |
| CN101242855A (zh) | 2005-08-22 | 2008-08-13 | 伊缪诺金公司 | Ca6抗原特异性细胞毒性偶联物及其应用方法 |
| CN101267841B (zh) | 2005-08-24 | 2012-10-10 | 免疫原公司 | 制备美登木素生物碱抗体缀合物的方法 |
| EP1962961B1 (en) | 2005-11-29 | 2013-01-09 | The University Of Sydney | Demibodies: dimerisation-activated therapeutic agents |
| SI1813614T1 (sl) | 2006-01-25 | 2012-01-31 | Sanofi 174 | Citotoksična sredstva, ki obsegajo nove tomajmicinske derivate |
| US7897568B2 (en) | 2006-03-03 | 2011-03-01 | Vinay K. Singh | Compositions for treatment of cancer |
| AR060978A1 (es) | 2006-05-30 | 2008-07-23 | Genentech Inc | Anticuerpos e inmunoconjugados y sus usos |
| CA2655379A1 (en) | 2006-06-22 | 2007-12-27 | Walter And Eliza Hall Institute Of Medical Research | Structure of the insulin receptor ectodomain |
| ES2435779T3 (es) | 2007-07-19 | 2013-12-23 | Sanofi | Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico |
| US9365629B2 (en) | 2007-09-24 | 2016-06-14 | University Of Zurich | Designed armadillo repeat proteins |
| MX2010011808A (es) | 2008-04-30 | 2011-03-04 | Immunogen Inc | Conjugados potentes y enlazadores hidrofilicos. |
| US8236319B2 (en) | 2008-04-30 | 2012-08-07 | Immunogen, Inc. | Cross-linkers and their uses |
| US8278419B2 (en) | 2008-10-31 | 2012-10-02 | Centocor Ortho Biotech Inc. | Fibronectin type III domain based scaffold compositions, methods and uses |
| CN105198908B (zh) * | 2009-02-05 | 2019-12-24 | 伊缪诺金公司 | 新型苯并二氮杂*衍生物 |
| WO2010093627A2 (en) | 2009-02-12 | 2010-08-19 | Centocor Ortho Biotech Inc. | Fibronectin type iii domain based scaffold compositions, methods and uses |
| FR2947269B1 (fr) * | 2009-06-29 | 2013-01-18 | Sanofi Aventis | Nouveaux composes anticancereux |
| SG181814A1 (en) | 2009-12-23 | 2012-07-30 | Avipep Pty Ltd | Immuno-conjugates and methods for producing them 2 |
| KR20170085143A (ko) | 2010-02-24 | 2017-07-21 | 이뮤노젠 아이엔씨 | 엽산염 수용체 1 항체와 면역접합체 및 이들의 용도 |
| HUE046360T2 (hu) | 2010-03-12 | 2020-03-30 | Debiopharm Int Sa | CD37-kötõ molekulák és azok immunkonjugátumai |
| CA2797274C (en) | 2010-04-30 | 2024-01-23 | Centocor Ortho Biotech Inc. | Stabilized fibronectin domain compositions, methods and uses |
| SG189929A1 (en) | 2010-10-29 | 2013-06-28 | Immunogen Inc | Novel egfr-binding molecules and immunoconjugates thereof |
| EP2632947A4 (en) | 2010-10-29 | 2015-03-18 | Immunogen Inc | NON-ANTAGONIST MOLECULES BINDING TO THE EGF RECEPTOR AND IMMUNOCONJUGATES THEREOF |
| PT2675480T (pt) * | 2011-02-15 | 2019-04-15 | Immunogen Inc | Métodos para preparação de conjugados |
| CA3182262A1 (en) | 2011-04-01 | 2012-10-04 | Immunogen, Inc. | Methods for increasing efficacy of folr1 cancer therapy |
| HK1211208A1 (zh) | 2012-08-22 | 2016-05-20 | Immunogen, Inc. | 細胞毒性苯並二氮呯衍生物 |
| HUE036433T2 (hu) * | 2012-11-05 | 2018-07-30 | Pfizer | Spliceostatin analógok |
| ES2815353T3 (es) * | 2014-09-03 | 2021-03-29 | Immunogen Inc | Derivados de benzodiazepina citotóxicos |
| CA2957964A1 (en) * | 2014-09-03 | 2016-03-10 | Immunogen, Inc. | Conjugates comprising cell-binding agents and cytotoxic agents |
-
2015
- 2015-09-02 ES ES15763739T patent/ES2815353T3/es active Active
- 2015-09-02 US US14/843,520 patent/US9669102B2/en not_active Expired - Fee Related
- 2015-09-02 MA MA054254A patent/MA54254A/fr unknown
- 2015-09-02 BR BR112017002963A patent/BR112017002963A2/pt not_active Application Discontinuation
- 2015-09-02 TW TW112135631A patent/TW202417447A/zh unknown
- 2015-09-02 TN TN2017000070A patent/TN2017000070A1/en unknown
- 2015-09-02 AU AU2015311987A patent/AU2015311987B2/en not_active Ceased
- 2015-09-02 WO PCT/US2015/048059 patent/WO2016036801A1/en not_active Ceased
- 2015-09-02 JP JP2017512775A patent/JP6606545B2/ja not_active Expired - Fee Related
- 2015-09-02 EP EP15763739.8A patent/EP3189056B1/en active Active
- 2015-09-02 DK DK15763739.8T patent/DK3189056T3/da active
- 2015-09-02 SG SG10201901824UA patent/SG10201901824UA/en unknown
- 2015-09-02 MX MX2017002758A patent/MX2017002758A/es unknown
- 2015-09-02 SG SG11201701455SA patent/SG11201701455SA/en unknown
- 2015-09-02 EA EA201790446A patent/EA034138B1/ru unknown
- 2015-09-02 KR KR1020177009021A patent/KR102632830B1/ko active Active
- 2015-09-02 RS RS20201000A patent/RS60751B1/sr unknown
- 2015-09-02 CA CA2959630A patent/CA2959630A1/en active Pending
- 2015-09-02 CR CR20170111A patent/CR20170111A/es unknown
- 2015-09-02 HU HUE15763739A patent/HUE051002T2/hu unknown
- 2015-09-02 EP EP20178715.7A patent/EP3778601A1/en not_active Withdrawn
- 2015-09-02 PL PL15763739T patent/PL3189056T3/pl unknown
- 2015-09-02 PT PT157637398T patent/PT3189056T/pt unknown
- 2015-09-02 TW TW104128985A patent/TWI697493B/zh not_active IP Right Cessation
- 2015-09-02 SM SM20200449T patent/SMT202000449T1/it unknown
- 2015-09-02 TW TW111102997A patent/TWI819474B/zh not_active IP Right Cessation
- 2015-09-02 SI SI201531320T patent/SI3189056T1/sl unknown
- 2015-09-02 PE PE2017000378A patent/PE20170775A1/es unknown
- 2015-09-02 KR KR1020247003505A patent/KR20240023671A/ko not_active Abandoned
- 2015-09-02 CN CN202210858832.1A patent/CN116514903A/zh active Pending
- 2015-09-02 LT LTEP15763739.8T patent/LT3189056T/lt unknown
- 2015-09-02 CN CN201580047847.8A patent/CN106604927B/zh not_active Expired - Fee Related
- 2015-09-02 TW TW109118465A patent/TWI757759B/zh active
-
2017
- 2017-02-22 IL IL250712A patent/IL250712B/en active IP Right Grant
- 2017-02-28 PH PH12017500358A patent/PH12017500358A1/en unknown
- 2017-03-02 DO DO2017000053A patent/DOP2017000053A/es unknown
- 2017-03-03 CL CL2017000507A patent/CL2017000507A1/es unknown
- 2017-03-28 CO CONC2017/0003011A patent/CO2017003011A2/es unknown
- 2017-04-03 EC ECIEPI201720133A patent/ECSP17020133A/es unknown
- 2017-04-28 US US15/581,749 patent/US10238751B2/en active Active
-
2019
- 2019-02-13 US US16/274,665 patent/US10722588B2/en active Active
- 2019-10-21 JP JP2019192174A patent/JP6802340B2/ja not_active Expired - Fee Related
-
2020
- 2020-04-21 IL IL281317A patent/IL281317B/en unknown
- 2020-04-21 IL IL274114A patent/IL274114A/en unknown
- 2020-06-15 US US16/901,754 patent/US11116845B2/en not_active Expired - Fee Related
- 2020-08-31 AU AU2020227006A patent/AU2020227006B2/en not_active Ceased
- 2020-09-04 CY CY20201100835T patent/CY1123325T1/el unknown
- 2020-11-26 JP JP2020195666A patent/JP7132311B2/ja active Active
-
2022
- 2022-03-22 IL IL291598A patent/IL291598A/en unknown
- 2022-04-12 AU AU2022202418A patent/AU2022202418B2/en not_active Expired - Fee Related
- 2022-08-24 JP JP2022133442A patent/JP2022166293A/ja not_active Ceased
- 2022-10-25 US US17/973,209 patent/US20230233697A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017527563A5 (enExample) | ||
| CN118434765A (zh) | Bcma单克隆抗体和抗体-药物偶联物 | |
| JP2014521591A5 (enExample) | ||
| RU2017144859A (ru) | Конъюгаты сконструированных антител с цистеиновыми заменами | |
| BR112020024915A2 (pt) | Conjugados de camptotecina | |
| AU2016279051B2 (en) | Delivery systems for controlled drug release | |
| CN113423430B (zh) | 含支链连接子的鹅膏毒素偶联物 | |
| HRP20160164T1 (hr) | Citotoksiäśni derivati benzodiazepina | |
| JP2021500412A (ja) | 単一分子量ポリサルコシンを含むリガンド−薬物−複合体 | |
| JP2015508074A5 (enExample) | ||
| JP2017529837A5 (enExample) | ||
| HRP20230275T1 (hr) | Antitijelo-lijek konjugati koji sadrže derivate ekteinascidina | |
| RU2020123953A (ru) | Ингибирующие bcl-xl соединения, обладающие низкой клеточной проницаемостью, и конъюгаты антитело-лекарственное средство, включающие их | |
| RU2017110068A (ru) | Конъюгаты, содержащие клеточносвязывающие агенты и цитотоксические агенты | |
| JP2018528162A5 (enExample) | ||
| RU2019129839A (ru) | Производные майтанзиноида с саморасщепляющимися пептидными линкерами и их конъюгаты | |
| JP2019512492A (ja) | Ｐｅｇ化薬物リンカー及びその中間体を調製するためのプロセス | |
| RU2016129894A (ru) | Ковалентно связанные конъюгаты хеликар-антитело против хеликара и их применения | |
| IL308504A (en) | Anti-ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof | |
| IL273384B2 (en) | Methods of preventing methionine oxidation in immunoconjugates | |
| TW202515620A (zh) | 抗體－藥物偶聯物靶向治療前列腺癌和其他腫瘤 | |
| ES2981742T3 (es) | Conectores para-amino-bencilo, proceso para su preparación y su uso en conjugados | |
| US20240269313A1 (en) | Conjugates comprising a phosphorus(v) moiety and a drug | |
| HK40069235A (en) | Delivery systems for controlled drug release | |
| TW202529814A (zh) | 用於綴合之化合物、綴合物及包含其之醫藥組成物 |